-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NkSlYtJTZNgnREzejuCnBGWAbt4LnWoTEuVTCc8A+NNhtxkeVGufRdca4wgbyzwC Rrkk5Kmb42PTRsgMwb/NMw== 0001104659-05-059116.txt : 20051205 0001104659-05-059116.hdr.sgml : 20051205 20051205162707 ACCESSION NUMBER: 0001104659-05-059116 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051129 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20051205 DATE AS OF CHANGE: 20051205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 051244516 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 8-K 1 a05-21288_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report:  November 29, 2005

(Date of earliest event reported)

 

ABIOMED, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

04-2743260

(State or Other Jurisdiction of
Incorporation)

 

(IRS Employer Identification
Number)

 

 

 

001-09585

(Commission File Number)

 

 

 

22 Cherry Hill Drive

Danvers, MA 01923

(Address of Principal Executive Offices, including Zip Code)

 

 

 

(978) 777-5410

(Registrant’s Telephone Number, including Area Code)

 

 

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Item 1.01 Entry into a Material Definitive Agreement.

 

Board Compensation Agreement

 

On November 29, 2005, our Board of Directors increased the annual compensation to Dorothy E. Puhy by $20,000, in consideration for Ms. Puhy’s recent appointment as lead director of our Board of Directors.

 

Software Acquisition and Implementation Agreements

 

On November 30, 2005, we entered into perpetual software license, an annual software maintenance agreement and a consulting services agreement with Answerthink, Inc., (Nasdaq: ANSR), a business and technology consulting firm, for the acquisition and implementation of SAP’s mySAP Business Suite.  Work is expected to begin immediately and the Company expects to complete the implementation of the new software early in Fiscal 2007.

 

The cost of the perpetual software license, first year maintenance and initial consulting services as defined within the agreements totals approximately $1.03 million.  This cost is subject to adjustments based on unforeseen changes in project scope, expansion of our software license through the purchase of additional user licenses (“seats”), additional employee training requirements and any cost efficiencies or inefficiencies that may occur during the implementation.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

ABIOMED, Inc.

 

 

 

 

 

 

 

By:

/s/ Charles B. Haaser

 

 

 

Charles B. Haaser

 

 

Controller

 

 

Principal Accounting Officer

 

 

Principal Financial Officer

 

 

 

 

 

 

Date: December 5, 2005

 

 

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----